The Potentials of Biosurfactants as Anti-Inflammatory and Anti-Viral Agents Against Covid-19: A Mini Review
DOI:
https://doi.org/10.56919/usci.1222.019Keywords:
Biosurfactants,, Anti-inflammatory,, Anti-viral,, COVID-19,, InterleukinsAbstract
Infection due to strain of severe acute respiratory syndrome coronavirus 2 (SARS COV2) has grown to be of global public health significance. Biotechnology uses living organisms such as microbes to produce metabolites like biosurfactants. Biosurfactants are ampiphilic surface active biomolecules that were proven to have therapeutic function against some groups of microbes including viruses. They also have anti-inflammatory potential through their interaction with viral membranes and macromolecules to decrease cytosolic phospholipase A2, which is the beginning of an anti-inflammatory response, and are recognized structurally by toll-like receptors (TLR-2), which are released when neutrophils are stimulated. They can also play vital role in aiding the human body to have inflammatory response. The functional groups of biosurfactants interact with the viruses membrane structure. Some groups of biosurfactants cause physiochemical processes that render viruses inactive. Therefore it can generally be understood that biosurfactants destroy the virus's envelope and the viral membrane's structures. The principle behind biosurfactant’s anti viral property is due to the hydrophilic properties that are within the acetyl groups. Additionally, the hydrophobic properties of biosurfactant are also important in making it to have antiviral activity. These activities of biosurfactants against viruses make it to be potential anti-inflammatory and anti-viral agents against Covid-19. Therefore this paper is aimed to produce a mini review on the anti-inflammatory and anti-viral potential against Covid-19. And the review also highlights some of the desirable properties and benefits of biosurfactants as anti-corona viruses.
References
Akhmerov, A. and Marbán, E. (2020). COVID-19 and the heart. Circ Research, 126:1443-1455. https://doi.org/10.1161/CIRCRESAHA.120.317055
Antony, S., Sukumaran, T. U., Rathinam, P., Reshmy, R., Binod, P., Pandey, A., & Sindhu, R. (2022). Biosurfactants in respiratory viruses and the Coronavirus disease 2019 pandemic. In Green Sustainable Process for Chemical and Environmental Engineering and Science (pp. 439-450). Academic Press. https://doi.org/10.1016/B978-0-323-85146-6.00017-6
Baeva, T., Gein, S., Kuyukina, M., Ivshina, I., Kochina, O andChereshnev. V. (2014). Effect of glycolipid Rhodococcusbiosurfactant on secretory activity of neutrophils in vitro. Bulletin of Experimental Biology and Medicine, 157:238. https://doi.org/10.1007/s10517-014-2534-9
Bluth, M., Smith-Norowitz, T., Hagler, M.,Beckford, R., Chice, S. and Shah, V.(2006).Sophorolipids decrease IgE production in U266 cells. Journal of Allergy and Clinical Immunology, 117. S202. https://doi.org/10.1016/j.jaci.2005.12.797
Bluth, M.H., Kandil, E., Mueller, C.M., Shah, V., Lin, Y-Y. and Zhang, H. (2006).Sophorolipids block lethal effects of septic shock in rats in a cecal ligation and puncture model of experimental sepsis.CriticalCare and Medicine, 34. https://doi.org/10.1097/01.CCM.0000196212.56885.50
Bonvila, X.R., Roca, S.F. and Pons, R.S.(2009). Inventors; NOVACYT, assignee. Antiviral use of cationic surfactant. United States patent application, 12/375:774.
Borsanyiova, M., Patil, A., Mukherji, R., Prabhune, A. and Bopegamage, S. (2016). Biological activity of sophorolipids and theirpossible use as antiviral agents. Folia Microbiology, 61:85-89. https://doi.org/10.1007/s12223-015-0413-z
Borzeix, C.F. (1999). Use of sophorolipids comprising diacetyl lactones as agent for stimulating skin fibroblast metabolism. Patent WO99/62479.
Chan, J.F-W., Yuan, S.,Kok,K-H.,To,KK-W.,Chu,H. and Yang, J. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395:514-523. https://doi.org/10.1016/S0140-6736(20)30154-9
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F. and Han,Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study. Lancet, 395:507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Chereshnev, V.,Gein, S., Baeva, T., Galkina, T., Kuyukina, M. and Ivshina, I. (2010). Modulation of cytokine secretion and oxidative metabolism ofinnate immune effectors by Rhodococcus biosurfactant. Bulletin of Experimental Biology and Medicine, 149:734. https://doi.org/10.1007/s10517-010-1039-4
El Khalloufi, F., & Oudra, B. (2023). Seaweeds as a New Source of Bioactive Compounds and Potent Biotechnological Applications. In Seaweed Biotechnology (pp. 229-287). Apple Academic Press. https://doi.org/10.1201/9781003300854-9
Fardami, A.Y., Kawo, A.H., Yahaya, S., Lawal, I., Sani, A.A. and Maiyadi, K.A. (2022). A Review on Biosurfactant Properties, Production and Producing Microorganisms. Journal of Biochemistry, Microbiology and Biotechnology, 10(1): 5-12. https://doi.org/10.54987/jobimb.v10i1.656
Fujioka, K., Kalish, F., Zhao, H., Lu, S., Wong, S. and Wong, R.J.(2017). Induction of heme oxygenase-1 attenuates theseverity of sepsis in a non-surgical preterm mouse model. shock: injury, inflammation, and sepsis. Laboratory Clinical Approaches, 47:242-250. https://doi.org/10.1097/SHK.0000000000000689
Gein, S., Kuyukina, M.,Ivshina, I., Baeva, T., Chereshnev, V. (2011) In vitro cytokine stimulation assay for glycolipid biosurfactant from Rhodococcus ruber: role of monocyte adhesion. Cytotechnology, 63:559-566. https://doi.org/10.1007/s10616-011-9384-3
Giri, S.S., Sen, S.S., Jun, J.W., Sukumaran, V., Park, S.C.(2016) Role of Bacillus subtilis VSG4-derived biosurfactant inmediating immune responses in Labeorohita. Fish Shell fish Immunology, 54: 220-229. https://doi.org/10.1016/j.fsi.2016.04.004
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L. and Castelli, A.(2020). Baseline characteristics and outcomesof 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. Journal of American Medical Association, 323: 1574-1581. https://doi.org/10.1001/jama.2020.5394
Gross, R.A. and Shah, V. (2007). Anti-herpes virus properties of various forms ofsophorolipids. Patent US. 200031243: A2
Gross, R.A., Shah, V. and Doncel, G. (2004). Spermicidal and virucidal properties of various forms of sophorolipids. Patent US. 20040242501:A1.
Gross, R.A., Shah, V. andDoncel, G. (2014). Virucidal properties of various forms of sophorolipids. Patent US, 8648055:B2.
Hagler, M., Smith-Norowitz, T., Chice, S., Wallner, S., Viterbo, D. and Mueller, C.(2007).Sophorolipids decreaseIgE production in U266 cells by downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6. Journal of Allergy and Clinical Immunology, 119. 263. https://doi.org/10.1016/j.jaci.2006.12.399
Hardin, R., Pierre, J., Schulze, R., Mueller, C.M., Fu, S.L. and Wallner S.R. (2007). Sophorolipids improve sepsis survival: effects of dosing and derivatives. Journal of Surgical Research, 142:314-319. https://doi.org/10.1016/j.jss.2007.04.025
Harshada, K. (2014). Biosurfactant: a potent antimicrobial agent. Journal of Microbiology Experiment, 1:173-177. https://doi.org/10.15406/jmen.2014.01.00031
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T. and Erichsen, S. (2020). SARS-CoV-2cellentry depends on ACE2 and TMPRSS2 and is blocked by aclinically proven protease inhibitor. Cell. 245-250. https://doi.org/10.1016/j.cell.2020.02.052
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J. and Hu, Y. (2020). Clinical features of patients infected with 2019 novel corona virus in Wuhan, China. Lancet, 395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Inès, M., Mouna, B., Marwa, E., & Dhouha, G. (2023). Biosurfactants as emerging substitutes of their synthetic counterpart in detergent formula: efficiency and environmental friendly. Journal of Polymers and the Environment, 1-13. https://doi.org/10.1007/s10924-023-02778-1
Karnwal, A., Shrivastava, S., Al-Tawaha, A. R. M. S., Kumar, G., Singh, R., Kumar, A. and Malik, T. (2023). Microbial Biosurfactant as an Alternate to Chemical Surfactants for Application in Cosmetics Industries in Personal and Skin Care Products: A Critical Review. Bio Med Research International. https://doi.org/10.1155/2023/2375223
Kişla, D., Gökmen, G. G., Evrendilek, G., Akan, T., Vlčko, T., Kulawik, P. and Özoğul, F. (2023). Recent developments in antimicrobial surface coatings: Various deposition techniques with nanosized particles, their application and environmental concerns. Trends in Food Science and Technology. https://doi.org/10.1016/j.tifs.2023.03.019
Kracht, M.A., Rokos, H., Özel, M., Kowall, M., Pauli, G. and Vater, J. (1999). Anti-viral and hemolytic activities of surfactin isoforms and their methyl ester derivatives. Journal of Antibiotics, 52:613-619. https://doi.org/10.7164/antibiotics.52.613
Liu, W. and Li, H. (2020) COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit humanheme metabolism. Preprint Revised On 2020:10.
Mahalaxmi, I., Kaavya, J., Mohana, D.S. and Balachandar, V. (2020): COVID19 and olfactory dysfunction: a possible associative approach towards neuro degenerative diseases. Journal of Cell Physiology, 1-8. https://doi.org/10.1002/jcp.29937
Morita, Y., Tadokoro, S., Sasai, M., Kitamoto, D. andHirashima, N. (2011). Biosurfactant mannosyl-erythritol lipid inhibits secretion of inflammatory mediators from RBL-2H3cells. BBA-GenSubjects, 1810:1302-1308. https://doi.org/10.1016/j.bbagen.2011.07.002
Mueller, C.M., Lin, Y., Viterbo, D., Pierre, J., Murray, S.A. and Shah, V. (2006). Sophorolipid treatment decreases inflammatory cytokine expression in an invitro model of experimental sepsis.A204. https://doi.org/10.1096/fasebj.20.4.A204-b
Nakanishi, M., Inoh, Y., Kitamoto, D. and Furuno, T. (2009). Nano vectors with a biosurfactant for gene transfection and drug delivery. Journal of Drug Delivery,Science and Technology, 5:411-420. https://doi.org/10.1016/S1773-2247(09)50031-7
Naughton, P.J., Marchant, R., Naughton, V. and Banat, I.M. (2019). Microbialbiosurfactants: current trends and applications in agricultural and biomedical industries. Journal of Applied Microbiology, 127: 12-28. https://doi.org/10.1111/jam.14243
Nitschke, M. and Marangon, C. A. (2022). Microbial surfactants in nanotechnology: recent trends and applications. Critical Reviews in Biotechnology, 42(2), 294-310. https://doi.org/10.1080/07388551.2021.1933890
Park, S.Y., Kim, J-H., Lee, S.J. and Kim, Y. (2013). Involvement of PKAand HO-1 signaling in anti-inflammatory effects of surfactin in BV-2 microglial cells. Toxicology and Applied Pharmacology, 268:68-78. https://doi.org/10.1016/j.taap.2013.01.017
Patel, P., Patel, R., Mukherjee, A., & Munshi, N. S. (2023). Microbial biosurfactants for green agricultural technology. In Sustainable Agriculture Reviews 60: Microbial Processes in Agriculture (pp. 389-413). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-24181-9_15
Paulino, B.N., Pessoa, M.G., Mano, M.C.R., Molina, G., Neri-Numa, I.A, Pastore, G.M. (2016) Current status in biotechnological production and applications of glycolipid biosurfactants. Applied Microbiology and Biotechnology,100:10265-10293. https://doi.org/10.1007/s00253-016-7980-z
Perfumo, A., Rudden, M., Marchant, R. and Banat, I. (2017). Biodiversity of biosurfactants and roles in enhancing the (bio) availability of hydrophobic substrates. In Cellular ecophysiology of microbe, Handbook of hydrocarbon and lipid microbiology. Springer; 1-29. https://doi.org/10.1007/978-3-319-20796-4_35-1
Ramasamy, S., Maheswari, P., Kavitha, P., Ravichandran,M.,Sas,B. and Ramchand, C. (2009). Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease. Indian Journal of Biochemistry and Biophysics, 46:79-85.
Rodrigues, L., Banat, I.M., Teixeira, J. and Oliveira, R.. (2006). Biosurfactants: potential applications in medicine. Journal Antimicrobial Chemotheraphy, 57: 609-618. https://doi.org/10.1093/jac/dkl024
Saimmai, A, Riansa-ngawong, W., Maneerat, S. and Dikit, P. (2020). Application of biosurfactants in the medical field. World Journal of Science and Technology, 17:154-166. https://doi.org/10.48048/wjst.2020.4748
Sajid, M.A., Singh, M.S., Cameotra, S., AlThubiani, A. (2020). Biosurfactants: potential applications as immunomodulator drugs. Immunology Letters, 223:71-77 https://doi.org/10.1016/j.imlet.2020.04.003
Santos, D.K.F., Rufino, R.D., Luna, J.M., Santos, V.A. andSarubbo, L.A. (2016). Biosurfactants: Multifunctional biomolecules of the 21st century. International Journal of Molecular Science, 17, https://doi.org/10.3390/ijms17030401
Santos, A.P.P., Silva, M.D.S., Costa, E.V.L., Rufino, R.D., Santos, V.A., Ramos, C.S., Saruboo,L.A.and Porto, A.L.F.(2017). Production andcharacterization of a biosurfactant produced by Streptomyces sp. DPUA 1559 isolated from lichens of the Amazon region. Brazilian Journal Medical and Biological Research, 51.6657-6657. https://doi.org/10.1590/1414-431x20176657
Sarangi, M. K., Padhi, S., Patel, L. D., Rath, G., Nanda, S. S., & Yi, D. K. (2022). Theranostic efficiency of biosurfactants against COVID-19 and similar viruses-A review. Journal of Drug Delivery Science and Technology, 103764. https://doi.org/10.1016/j.jddst.2022.103764
Shah, V., Doncel, G., Seyoum, T., Eaton, K., Zalenskaya, I., Hagver, R. (2005). Sophorolipids: novel glycolipid preventive agents for conception and sexual transmission. Antimicrobial Agents and Chemotheraphy, 49: 4093-4100. https://doi.org/10.1128/AAC.49.10.4093-4100.2005
Sil, M., Mitra, S., & Goswami, A. (2023). Probiotics and immunity: An overview. Viral, Parasitic, Bacterial, and Fungal Infections, 847-861. https://doi.org/10.1016/B978-0-323-85730-7.00007-2
Singh, A. S. (2023). 15 Recent Advancements in Environmental Biotechnology: Bio surfactant is a Potent Bioremediation Method for Heavy Metals. Applications of Environmental Biotechnology for Global Sustainability, 112.
Singh, P. and Cameotra, S.S. (2004). Potential applications of microbial surfactants in biomedical sciences. Trends in Biotechnology, 22:142-146. https://doi.org/10.1016/j.tibtech.2004.01.010
Sokhela, S., Lalla-Edward, S., Siedner, M. J., Majam, M., & Venter, W. D. F. (2023). Roadmap for achieving universal antiretroviral treatment. Annual Review of Pharmacology and Toxicology, 63, 99-117. https://doi.org/10.1146/annurev-pharmtox-052020-094321
Subramaniam, M. D., Venkatesan, D., Iyer, M., Subbarayan, S., Govindasami, V., Roy, A. & Vellingiri, B. (2020). Biosurfactants and anti-inflammatory activity: A potential new approach towards COVID-19. Current Opinion in Environmental Science and Health, 17, 72-81. https://doi.org/10.1016/j.coesh.2020.09.002
Takeda, T., Sasai, M., Adachi, Y., Ohnishi, K., Fujisawa, J. and Izawa, S. (2017). Potential role of haeme metabolism in the inducible expression of heme oxygenase-1. BBA - General Subject, 1861:1813-1824. https://doi.org/10.1016/j.bbagen.2017.03.018
Tripathy, D. B., Bhati, K., & Gupta, A. (2023). Role of Surfactants against Covid‐19: A Scientific Approach. In Macromolecular Symposia (Vol. 407, No. 1, p. 2100415). https://doi.org/10.1002/masy.202100415
Ukaegbu, C. I., Shah, S. R., Alara, R. O., & Thonda, O. A. (2023). Biosurfactants as Potential Antitumor Agents. In Advancements in Biosurfactants Research (pp. 439-460). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-031-21682-4_20
Vakil, H., Sethi, S., Fu, S., Stanek, A., Wallner, S., Gross, R.(2010).Sophorolipids decrease pulmonary inflammation in a mouse asthma model. Nature, 90. 392.
Vanreppelen, G., Wuyts, J., Van Dijck, P., and Vandecruys, P. (2023). Sources of Antifungal Drugs. Journal of Fungi, 9(2), 171. https://doi.org/10.3390/jof9020171
Venugopal, A., Ganesan, H., Raja, S. S. S., Govindasamy, V., Arunachalam, M., Narayanasamy, A. & Vellingiri, B. (2020). Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots. Current Opinion in Environmental Science & Health, 17, 8-13. https://doi.org/10.1016/j.coesh.2020.05.003
Vollenbroich, D., Ozel, M., Vater, J., Kamp, R.M. and Pauli, G. (1997). Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals, 25: 289-297. https://doi.org/10.1006/biol.1997.0099
Wang, W., He, J. and Wu, S. (2020). The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis. Medrxiv. ppzbmed-10.1101.2020.02.26.20026989
Yang, M. (2020). Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. Available at: SSRN3527420 2020.This article was published, and it explains the SARS-CoV-2 outbreak, treatment and other related approaches towards COVID-19. https://doi.org/10.2139/ssrn.3527420
Zhang, Y., Liu, C., Dong, B., Ma, X., Hou, L. and Cao, X. (2015). Anti-inflammatory activity and mechanism of surfactin in lipopolysaccharide-activated macrophages. Inflammation, 38:756-764. https://doi.org/10.1007/s10753-014-9986-y
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 UMYU Scientifica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
